4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0001104659-23-001088
Chief Executive Officer sold 5,073 shares at $1.69 ($8,594)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Rawcliffe Adrian Chief Executive Officer | 2023-01-04 | Sale | −5,073 | $1.69 | $8,594 | 6,631 | D |
| Open-market sales · 5,073 sh · avg $1.69 · $8,594 | |||||||
Loading xslF345X03/tm231655-1_4seq1.xml…